Eurand S.p.A.

Non-Quoted Public Company
Via M Luther King 13, Pessano con Bornago,  I-20060, Italy
()39 02 954281, 39 02 95745012 fax, http://www.eurand.com

Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: The Company specialises in developing enhanced pharmaceutical and bio-pharmaceutical products using drug delivery technologies

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Eurand S.p.A., News and Information

Patent No. 7,632,521 Issued on Dec. 15, Assigned to Eurand for Controlled Release Potassium Chloride Tablets (Ohio Inventors)
US Fed News Service, Including US State News; 12/16/2009; 479 words; ...The inventors were issued U.S. Patent No. 7,632,521 on...The patent has been assigned to Eurand Inc., Vandalia. According to the abstract released by the U.S. Patent & Trademark Office...amp;Sect2=HITOFF&p=1&u=%2Fnetahtml...

Reportlinker Adds Pulmonary Drug Delivery Technologies - A Global Market Perspective.
PR Newswire; 11/18/2009; 2277 words; ...17 FDA Bans the Use of CFC's in Metered Dose Inhalers 18 7...Over Ventaira Pharmaceuticals 19 Eurand Takes Over SourceCF 20 Aradigm...Launches SymbicortA' 22 Dey, L.P Unveils Perforomist(TM) 22...Medical Plc (UK) 24 Dey L.P. (USA) 24 GlaxoSmithKline...

Small Cap Stocks to Watch - EURX, VADX, NANO.
M2 Presswire; 11/13/2009; 876 words; ...www.smallcapreview.com. Eurand N.V. (Nasdaq: EURX) $12...higher dose, respectively (p < 0.001 compared to baseline...adverse events. What They Do: Eurand is a specialty pharmaceutical...Today announced that the U.S. Food and Drug Administration...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1469 words; ...was seen vs. placebo. o Eurand NV, of Milan, Italy...protein and other nutrients. Eurand is in the process of submitting...treatment with the company's Selective Electrochemical...statistically significant (p<0.01) improvement...based AstraZeneca plc's KuDOS Pharmaceuticals unit...

Altus Starts Phase III Studies Of Pancreatic Enzyme Product.
BIOWORLD Today; 11/3/2009; 1355 words; ...always take the lion's share of the market over...tolerated and improved fat (p <0.001) and protein (p <0.001) absorption...Mass.-based company's stock (NASDAQ:ALTU...In 2008, IPO hopeful Eurand International SpA expects...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.